Display Settings:

Format

Send to:

Choose Destination
    Pain Med. 2009 Oct;10(7):1325-30.

    A clinical trial of gene therapy for chronic pain.

    Source

    Diamyd Inc, Pittsburgh, PA, USA.

    Abstract

    The first human trial of gene therapy for chronic pain, a phase 1 study of a nonreplicating herpes simplex virus (HSV)-based vector engineered to express preproenkephalin in patients with intractable pain from cancer, began enrolling subjects in December 2008. In this article, we describe the rationale underlying this potential approach to treatment of pain, the preclinical animal data in support of this approach, the design of the study, and studies with additional HSV-based vectors that may be used to develop treatment for other types of pain.

    PMID:
    19818042
    [PubMed - indexed for MEDLINE]
    PMCID: PMC3032602
    Free PMC Article

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk